VAERS reports by lot

Pfizer COVID-19 lot MY9550: VAERS reports

89 VAERS reports list lot MY9550 as a Pfizer COVID-19 vaccine, received between 2025-09-13 and 2026-04-29. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
89
Reports
3%
Marked serious
1
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5826%
Neurological2712%
Cardiac / Cardiovascular2210%
Allergic / Anaphylactic2210%
Musculoskeletal2110%
General / Systemic (non-local)209%
Dermatological (non-injection-site)199%
Gastrointestinal178%
Respiratory73%
Psychiatric / Neuropsychiatric42%
Thrombotic / Hematological31%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Florida12
Texas11
Michigan7
Ohio5
Illinois4
New York4
Virginia4
California4
Oregon4
New Jersey3
Georgia3
Pennsylvania3

Reports by month received

MonthReportsBar
2025-0932
2025-1032
2025-119
2025-128
2026-012
2026-022
2026-032
2026-042

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): ME6072 · MY9547 · MY9548 · NA0587 · NA0589 · NA0590

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.